Jordan · Delayed Price · Currency is JOD General Investment Statistics
Total Valuation
ASE:GENI has a market cap or net worth of JOD 28.30 million. The enterprise value is 27.68 million.
| Market Cap | 28.30M |
| Enterprise Value | 27.68M |
Important Dates
The last earnings date was Sunday, February 15, 2026.
| Earnings Date | Feb 15, 2026 |
| Ex-Dividend Date | May 4, 2025 |
Share Statistics
ASE:GENI has 10.00 million shares outstanding.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.30% |
| Owned by Institutions (%) | 5.98% |
| Float | 2.67M |
Valuation Ratios
The trailing PE ratio is 13.77.
| PE Ratio | 13.77 |
| Forward PE | n/a |
| PS Ratio | 2.29 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.47 |
| EV / Sales | 2.24 |
| EV / EBITDA | 12.75 |
| EV / EBIT | 16.12 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.24% and return on invested capital (ROIC) is 4.92%.
| Return on Equity (ROE) | 7.24% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.92% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.31% |
| Revenue Per Employee | 90,246 |
| Profits Per Employee | 14,999 |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASE:GENI has paid 400,632 in taxes.
| Income Tax | 400,632 |
| Effective Tax Rate | 16.32% |
Stock Price Statistics
The stock price has decreased by -4.07% in the last 52 weeks. The beta is 0.01, so ASE:GENI's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -4.07% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 46.33 |
| Average Volume (20 Days) | 5,537 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASE:GENI had revenue of JOD 12.36 million and earned 2.05 million in profits. Earnings per share was 0.21.
| Revenue | 12.36M |
| Gross Profit | 4.36M |
| Operating Income | 1.72M |
| Pretax Income | 2.46M |
| Net Income | 2.05M |
| EBITDA | 2.17M |
| EBIT | 1.72M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 623,893 in cash and n/a in debt, with a net cash position of 623,893 or 0.06 per share.
| Cash & Cash Equivalents | 623,893 |
| Total Debt | n/a |
| Net Cash | 623,893 |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 29.81M |
| Book Value Per Share | 2.98 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 35.30%, with operating and profit margins of 13.89% and 16.62%.
| Gross Margin | 35.30% |
| Operating Margin | 13.89% |
| Pretax Margin | 19.86% |
| Profit Margin | 16.62% |
| EBITDA Margin | 17.55% |
| EBIT Margin | 13.89% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 4.24% |
| Earnings Yield | 7.26% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |